Skip to main content Back to Top
Advertisement

Rapid Sequence Intubation in Special Populations

Broadcast Date: March 31, 2022

 

Subscribe on iTune PodcastsListen on Google PlaySubscribe to Stitcher Podcasts Listen on Spotify Subscribe to TuneIn PodcastsSubscribe to iHeartRadio

Medications utilized in rapid sequence intubation vary in preference and dosing in special populations. This podcast episode focuses on RSI in obese patients.

SPEAKERS

Lewis Hunter ReeseDr. L. Hunter Reese is an emergency medicine clinical pharmacy specialist practicing at MetroHealth Medical Center in Cleveland, Ohio. He earned his Doctor of Pharmacy degree from Ohio Northern University and completed his PGY1 residency at MetroHealth. Following residency, Dr. Reese worked to establish clinical pharmacy services in the MetroHealth emergency department. His professional interests include antimicrobial stewardship, sepsis, and antithrombotic reversal. Dr. Reese is a member of the ASHP Emergency Care Section Advisory Group.

Vicki BasalygaVicki Basalyga, PharmD MAS, BCPS, BCPPS is the Director of Member Relations for the Clinical Specialists and Scientists at ASHP. In addition to her Director role, Vicki assists in clinical policy development as the Secretary for the Council on Therapeutics, serves as a representative for ASHP on numerous national clinical initiatives and works with members to create essential tools and resources for leaders, practitioners and educators.

 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.